Caption Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Caption Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,000	Closed	-$511K	–	1520
2020 Q4	$511K	Buy	+30,000	New	+$376K	0.01%	735

Caption Management's FPRX Position: Q2 2021 in Review

Caption Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 2,700 shares — an estimated $102K sold.

Caption Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $102K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Caption Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Caption Management sold 2,700 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $102K.
Caption Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Caption Management's Five Prime Therapeutics, Inc. position peaked at $102K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Caption Management's 13F filing for Q2 2021, filed 16 Aug 2021.